Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit.

When IPW was implemented, borderline significance was observed for five-year RFS, with better results for the Post-BCG group (68.9% vs. 61.2%; p = 0.063) ( Figure 4 C).

also in 7,017 other papers

For other IPW survival analyses, differences in RFS and PFS did not reach statistical significance ( Figure 4 D). 4.

also in 111,027 other papers